What question did this study set out to answer?

To assess the feasibility and safety of an ERAS (Enhanced Recovery After Surgery) program in minimally-invasive heart valve surgery.

February 2, 2026

Interdisciplinary and cross-sectoral perioperative care model in cardiac surgery: ERAS implementation in the setting of minimally-invasive heart valve surgery (INCREASE) - results of a randomized controlled trial.

Key Result

The implementation of an ERAS model in minimally-invasive heart valve surgery was found to be feasible and safe, but did not reduce hospital stay length.

Key Points

To assess the feasibility and safety of an ERAS (Enhanced Recovery After Surgery) program in minimally-invasive heart valve surgery.
Conducted a randomized controlled trial
Implemented ERAS protocols in the surgical care model
Evaluated outcomes in a population undergoing minimally-invasive heart valve surgery
ERAS was demonstrated to be feasible and safe in minimally-invasive heart valve surgery
No significant reduction in length of hospital stay was observed
Exploratory analyses indicate the need for further evaluation of ERAS concepts

Structured PICO

Does ERAS implementation reduce length of hospital stay in patients undergoing minimally-invasive heart valve surgery?

Population

Patients undergoing minimally-invasive heart valve surgery (MIHS)

Intervention

Enhanced Recovery After Surgery (ERAS) implementation

Outcome

Length of hospital stay

ERAS implementation in minimally-invasive heart valve surgery is feasible and safe but did not reduce length of hospital stay.

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

ERAS is feasible and safe in MIHS. The trial did not demonstrate a reduction in length of hospital stay in the population studied. Exploratory analyses suggest that further evaluation of ERAS concepts is justified.

Mark Helpful

Bookmark

Relay